CS1:PA:PA-Amundi IBEX 35 UCITS ETF Acc (EUR)

ETF | Others |

Last Closing

USD 354.9

Change

-1.15 (-0.32)%

Market Cap

USD 0.11B

Volume

547.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.01 (+0.03%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-6.10 (-1.18%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-4.80 (-1.29%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

-0.34 (-0.99%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-2.48 (-0.94%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-8.00 (-1.74%)

USD 7.99B
WLD:PA Lyxor UCITS MSCI World D-EUR

-3.51 (-1.04%)

USD 7.49B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.08 (-1.18%)

USD 7.42B
HHH:PA HSBC S&P 500 UCITS ETF

-0.62 (-1.18%)

USD 7.22B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.57 (-0.70%)

USD 5.38B

ETFs Containing CS1:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.27% 99% N/A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.27% 99% N/A 89% A-
Trailing 12 Months  
Capital Gain 31.52% 95% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.52% 95% A 91% A-
Trailing 5 Years  
Capital Gain 151.13% 96% N/A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 151.13% 95% A 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.76% 86% B+ 82% B
Dividend Return 15.76% 83% B 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.73% 51% F 75% C
Risk Adjusted Return 123.78% 95% A 97% N/A
Market Capitalization 0.11B 29% F 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.